Comparison of Efficacy of Anti-interleukin-17 in the Treatment of Psoriasis Between Caucasians and Asians : A Systematic Review and Meta-Analysis
Background: Interleukin-17 (IL-17) monoclonal antibody drugs have been increasingly significant in the treatment of psoriasis, but it is not clear whether the efficacy is equivalent across ethnicities. Objective: To explore the differences of short-term efficacy of IL-17 inhibitors between Caucasians and Asians. Methods: The pooled log risk ratio (logRR) between the groups was estimated. The meta-
